Men's Cancer
Screening Blood Test
6 Markers · Only ₹3,299
⚠️ Prostate, liver, pancreatic and colorectal cancers show almost no symptoms until Stage 3 or 4. Early detection through tumour markers is the only way to catch them in time.
A 6-marker tumour panel for men. Screens for the most common cancers affecting men — prostate, colorectal, liver, pancreatic and testicular cancers — with a single blood draw at your home. No fasting. accuracy from NABL Accredited Labs. Recommended for all men above 40 annually.
Why Every Man Above 40 Needs Annual Cancer Screening
These are the clinical facts that make this test one of the most important health decisions a man can make.
What Each Marker Tests and Detects
Each of the 6 markers targets specific cancer types — with normal reference ranges clearly marked. Tap any marker to expand full clinical detail.
CA 19.9 is the primary tumour marker for pancreatic cancer — one of the deadliest cancers due to its typically late diagnosis. It is also elevated in cancers of the bile duct, gallbladder, stomach and colorectal tract. Pancreatic cancer is notoriously asymptomatic in early stages; CA 19.9 is one of the few tools available for early detection before symptoms develop.
CEA is the most widely used tumour marker for colorectal cancer — the third most common cancer globally and increasingly prevalent in India. It is also elevated in lung, breast, stomach and pancreatic cancers. CEA is used both for initial screening and for monitoring treatment response and recurrence after cancer surgery.
AFP is the primary marker for hepatocellular carcinoma (HCC) — primary liver cancer. India has one of the highest rates of liver cancer globally, largely driven by Hepatitis B and C infections and alcoholic liver disease. AFP is also elevated in testicular germ cell tumours and some pancreatic cancers. Liver cancer has a much better prognosis when detected at small tumour sizes — AFP surveillance makes this possible.
PSA is produced exclusively by the prostate gland. Total PSA is the foundational screening test for prostate cancer — the second most common cancer in Indian men. An elevated PSA triggers further investigation (PSA Free ratio, biopsy, MRI). PSA screening allows prostate cancer to be caught at Stage 1–2 when it is completely curable, versus Stage 4 when it is not.
PSA Free is the clinically critical companion to PSA Total. When Total PSA falls in the 4–10 ng/mL grey zone, the Free PSA percentage (Free ÷ Total × 100) distinguishes between benign prostatic hyperplasia (BPH) and prostate cancer with high accuracy. A low Free PSA % (<15%) strongly suggests malignancy; a high Free PSA % (>25%) reassures that the elevation is likely benign. Including PSA Free prevents unnecessary biopsies while ensuring real cancers are not missed.
In men, elevated Beta HCG is a key marker for testicular germ cell tumours (seminomas and non-seminomas) — the most common solid tumour in men aged 15–45. It is also elevated in choriocarcinoma, bladder cancer and some liver and lung cancers. Beta HCG combined with AFP provides a comprehensive testicular cancer screening profile and is used for monitoring treatment response and detecting recurrence after surgery.
Who Should Book the Men's Cancer Screening Panel?
This test is recommended for any man who fits any of these profiles — the earlier you screen, the better your outcomes.
Why NABL Accreditation Matters for Cancer Marker Tests
Tumour marker tests require precision instrumentation and strict quality controls. A false positive causes unnecessary anxiety; a false negative provides dangerous false reassurance.
Direct-to-Patient Pricing.
No Middlemen. Ever.
The same 6 markers at a hospital or corporate lab typically cost ₹6,000–8,000. We charge ₹3,299 — because we don't pay commissions to aggregators.
From Booking to Report from NABL Accredited Labs — 5 Easy Steps
No fasting. No queues. No travel. A single blood draw at your home delivers all 6 tumour marker results within 9 hours.
Men's Cancer Screening vs Other Packages
Compare the closest alternatives and book directly from here.
Frequently Asked Questions
Everything you need to know about the Men's Cancer Screening Blood Test before booking.
Free Home Collection Across Hyderabad
Confidential home visits — our phlebotomist comes to your door at free on bookings above ₹1,000.
Find Lotus Diagnostics in Nizampet
🍦 Lotus Diagnostics — Nizampet, Hyderabad
Get DirectionsSunday: 8:00 AM – 1:00 PM
Your Health Is Worth One Blood Test.
₹3,299 · 6 Tumour Markers · PSA Total + Free · CEA · AFP · CA 19.9 · Beta HCG · No Fasting · Free Home Collection · Confidential Reports from NABL Accredited Labs in 9 Hours
Men's Cancer Screening Blood Test in Nizampet, Hyderabad — Complete Guide
Why Annual Tumour Marker Screening Saves Lives
In India, prostate cancer is the second most common cancer in men. Colorectal cancer cases are rising rapidly in urban populations. Liver and pancreatic cancers are among the most deadly — because they show almost no symptoms until Stage 3 or 4. Tumour marker blood tests are a critical early warning system. A single abnormal PSA result caught early has led to thousands of successful prostate cancer treatments.
At Lotus Diagnostics Nizampet, this 6-marker oncology panel costs ₹3,299 — with free confidential home collection and reports from NABL Accredited Labs on WhatsApp within 9 hours. No fasting required.
What's Unique About This Panel
- PSA Free included — prevents unnecessary biopsies in grey-zone PSA results
- 5 cancer types in a single blood draw — no fasting, no imaging
- NABL-accredited immunoassay accuracy — accepted by all oncologists
- Reference ranges printed on report — easy for doctor review
- Confidential — report sent only to your personal WhatsApp
- Same markers at hospital labs: ₹6,000–8,000. Here: ₹3,299.
Related Health Packages
Explore other tests popular with patients in Nizampet and nearby areas.
Serving Nizampet · Pragathi Nagar · Bachupally · Miyapur · Kukatpally and nearby areas. Book a test or arrange free home sample collection (₹1,000+).
Learn more about cancer from the World Health Organization.